Status:
ACTIVE_NOT_RECRUITING
KidneyCare Cohort Study (KCC-S)
Lead Sponsor:
University of Utah
Conditions:
Kidney Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This research study aims to learn how lifestyle factors (e.g., obesity) impact the risk of developing kidney cancer and impact survival after nephrectomy (removal of a kidney). The study team's long-t...
Detailed Description
If patients decide to participate in this study, they will be asked to complete the following assessments: Health questionnaires: The study team will ask participants to complete this health question...
Eligibility Criteria
Inclusion
- Renal Cell Cancer (RCC) stage I-IV
- Undergoing radical nephrectomy (entire kidney resection) or partial nephrectomy
- Patients with or without prior systemic therapy for renal cell carcinoma and \> 1 year from systemic therapy for other non-cutaneous malignancy
- Cytoreductive nephrectomy (nephrectomy in the setting of limited metastatic disease)
Exclusion
- Does not consent to tissue collection
- Patients with only an MRI abdomen/pelvis within 4 months of surgery will be excluded
- Known biopsy-proven non-clear cell RCC
Key Trial Info
Start Date :
March 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 9 2029
Estimated Enrollment :
161 Patients enrolled
Trial Details
Trial ID
NCT06898632
Start Date
March 1 2021
End Date
January 9 2029
Last Update
May 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huntsman Cancer Institute
Salt Lake City, Utah, United States, 84112